ARTICLE | Clinical News
PRO 2000 Gel: Began Phase I/II trial enrollment
August 21, 2000 7:00 AM UTC
IPIC acquired exclusive global rights to PRO 2000 from Procept Inc. (Cambridge, Mass.), a subsidiary of HeavenlyDoor.com Inc. (HVDC, Coral Springs, Fla.) (see BioCentury, June 19). ...